Kazia Therapeutics Ltd ADR (KZIA)

US · Healthcare · Biotechnology

$7.18+2.57%

Last close · 2026-11-06

Key statistics

Market cap

$82.0M

Forward P/E

12.8

P/B

3.37

Book value

$2.88

EPS (TTM)

$-6.85

52-week high

$17.40

52-week low

$4.86

50-day MA

$9.56

200-day MA

$10.56

Beta

2.36

Analysts rate Kazia Therapeutics Ltd ADR a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $29.30.

Insiders

15.42%

Institutions

32.12%

Fund	Stake
Boxer Capital Management, LLC	4.33%
F.L.Putnam Investment Management	3.21%
Bleichroeder LP	3.09%
Ikarian Capital, LLC	3.06%
Dauntless Investment Group, LLC	2.74%
Stonepine Capital Management Llc	2.67%
Point72 Asset Management, L.P.	1.55%
Ensign Peak Advisors Inc	0.86%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Kazia Therapeutics Ltd ADR — free to start.

Data updated 2026-11-07.